Durham, NC (Sept. 7, 2010) – Mi-Co, the Mobile Data Collection company, today announced that it has received a Small Business Innovation Research (SBIR) grant award from the National Cancer Institute of the National Institutes of Health. The funded project is to develop a healthcare software solution in conjunction with Dr. Amy Abernethy, Director of the Duke University Cancer Care Research Program. The Digital Pen based solution will enable more efficient capture of medical oncology progress notes and clinical trials data, simultaneously. Mi-Co’s Mi-Forms for Digital Pen, already used in several Fortune 500 companies, leading hospital systems, and government agencies will soon provide even more possibilities for partners and customers in the healthcare arena.
The project titled “Clinical trials data collection during patient care using a novel technology solution” will begin immediately in conjunction with Dr. Amy Abernethy and other physicians at Duke University using Mi-Co Mi-Forms software technology and Digital Pen hardware developed by Anoto Group AB. According to Dr. Abernethy, “Within the Duke Cancer Care Research Program, we have previously used Mi-Co's pen-based technology for our electronic data collection because it allows us to efficiently and accurately capture patient data, such as extensive progress notes, and share that data electronically with all members of the clinical and research team quickly and easily, in a way that supports our workflow and interaction with patients. Keyboard-based applications and regular paper simply cannot match the ease of use and efficiency of this technology, which solves a key problem for us and provides an important "bridge" from paper to electronic health records. Doctors are writers, not typers.”
For a recently released article about alternative data input options for electronic medical record (EMR) systems that suggests ways to overcome barriers to EMR adoption, please contact firstname.lastname@example.org.
For more information about Mi-Forms and the Mi-Co solution for mobile electronic data collection in Clinical Trials and Healthcare, please contact Mi-Co through www.mi-corporation.com or contact Mi-Co.
The project described is supported by Award Number R43CA150466 from the National Cancer Institute. The content is solely the responsibility of Mi-Co and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.”
Mi-Co Media Contact: Gautham Pandiyan, Director of Sales & Marketing, 888-621-6230, email@example.com